Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wade Clapp

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Science Advances|January 30, 2026
Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosisDana K Mitchell, Kylee Brewster, Li Jiang, et al.
Science Advances|June 20, 2025
TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibromaMohannad Abu-Sultanah, Zhuan Zhou, Chunhui Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2023
Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor ProgressionDana K Mitchell, Breanne Burgess, Emily E White, et al.
Human Molecular Genetics|October 19, 2018
A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomasJeffrey R Gehlhausen, Eric Hawley, Benjamin Mark Wahle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2019
Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1Smita Bhatia, Yanjun Chen, F Lennie Wong, et al.
Pharmacological Research|February 4, 2024
New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer typesSilpa Gampala, Hye-Ran Moon, Randall Wireman, et al.
Gastroenterology|December 23, 2025
Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal AdenocarcinomaNayela N Chowdhury, Dana K Mitchell, Kadri Kangro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2023
Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C Flint, Dana K Mitchell, Steven P Angus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2024
Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C Flint, Dana K Mitchell, Steven P Angus, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2011
Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meetingJakub Tolar, Jennifer E Adair, Michael Antoniou, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Science Advances|January 30, 2026
Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosisDana K Mitchell, Kylee Brewster, Li Jiang, et al.
Science Advances|June 20, 2025
TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibromaMohannad Abu-Sultanah, Zhuan Zhou, Chunhui Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2023
Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor ProgressionDana K Mitchell, Breanne Burgess, Emily E White, et al.
Human Molecular Genetics|October 19, 2018
A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomasJeffrey R Gehlhausen, Eric Hawley, Benjamin Mark Wahle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2019
Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1Smita Bhatia, Yanjun Chen, F Lennie Wong, et al.
Pharmacological Research|February 4, 2024
New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer typesSilpa Gampala, Hye-Ran Moon, Randall Wireman, et al.
Gastroenterology|December 23, 2025
Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal AdenocarcinomaNayela N Chowdhury, Dana K Mitchell, Kadri Kangro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2023
Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C Flint, Dana K Mitchell, Steven P Angus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2024
Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C Flint, Dana K Mitchell, Steven P Angus, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2011
Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meetingJakub Tolar, Jennifer E Adair, Michael Antoniou, et al.
Pageof 12